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PreviewsThough it has been known for decades
that calorie restriction is an effective way
to combat obesity-related insulin resis-
tance (and also aging), the present study
reveals a mechanism for these effects.
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Genome-wide association studies (GWAS) have been applied to complex diseases such as diabetes and
hypertension, successfully uncovering strong gene associations of potential pathophysiologic significance.
Recently, two studies (Ko¨ttgen et al., 2010; Chambers et al., 2010) have been applied to uncover genes
relevant to the pathophysiology of chronic kidney disease (CKD).Chronic kidney disease (CKD) is defined
as an irreversible reduction in glomerular
filtration rate (GFR), the first process of
urine production that often progresses to
end stage renal disease (ESRD), whereby
the level of GFR falls below the minimal
level to sustain life. The final common
pathway to ESRD, achieved regardless
of the initiating event, is characterized by
glomerular sclerosis, interstitial fibrosis,
and inflammation and loss of kidney func-
tion. The burden of ESRD worldwide is
growing, and as much as 13% of the
United States population is at risk (Coresh
et al., 2007). Animal studies have focused
on the profibrotic and inflammatory roles
of the renin-angiotensin system (RAS)
(Chevalier et al., 2009), and inhibition of
this system is the focus of current therapy.
This approach has proven only partially
successful, as such treatment delays
rather than prevents ESRD. Thus, theneed to identify better targets to prevent
ESRD is urgently needed. Genome-wide
association studies (GWAS) have been
widely used since 2005 (Klein et al.,
2005) to understand the underlying ge-
netic component(s) of complex pheno-
types, i.e., phenotypes that do not exhibit
classical Mendelian inheritance resulting
from a single gene alteration (Lander
and Schork, 1994). More than any other
approach, these studies have reproduc-
ibly associated closely linked genetic
loci, identified by single nucleotide poly-
morphisms (SNPs), to these traits. At
best, they have led to the delineation in
many parts of the human genome of
sequences showing association with
common disease traits, e.g., diabetes,
obesity, hypertension, etc. and have also
been used to find association with normal
physical traits such as height, hair, and
eye color (Hindorff et al., 2010). GWASrequire the study of the DNA from several
thousands of individuals with and without
a demonstrable and measurable pheno-
type. SNPs associated with these charac-
teristics are identified by hybridization
with known SNP arrays. An international
project has developed a haplotype map
(HapMap; http://hapmap.ncbi.nlm.nih.
gov/) of the genome, which identifies
variable regions of the human genome
and associated genetic variation. Once
the associated areas of DNA have been
located, there follows a search in the
region to find candidate genes potentially
involved in the pathologic physiology
responsible for susceptibility to the trait
or disease under investigation. In most
GWAS, each discovered DNA variant
usually has only a small impact on the
increased risk of the disease, as was pre-
dicted 50 years ago by D.S. Falconer
(1960), and that is also the case in two11, June 9, 2010 ª2010 Elsevier Inc. 451
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Previewsrecent papers by Ko¨ttgen et al. (2010) and
Chambers et al. (2010).
Ko¨ttgen et al. (2010) and Chambers
et al. (2010) apply GWAS to large numbers
of CKD patients. In these studies, GFR is
not assessed directly but instead is
derived from values of serum creatinine
and cystatin C, two generally accepted
but flawed indirect markers of glomerular
filtration. This weakness is fully recog-
nized by both groups. In a search for
common genetic variants associated
with CKD and using a now standard
approach, each study identified four vari-
able genomic regions that had strong
association with the estimated glomerular
filtration rates (eGFR) calculated by either
serum creatinine (eGFRcreat) or serum
cystatin C concentrations (eGFRcyst). Of
the 20 genes close to these four regions,
several genes were highlighted based on
the strength of the association to CKD,
higher renal expression relative to other
organs, the presence of nonsynonymous
mutations, and/or their suspected func-
tion or relationship to kidney disease.
These genes had metabolic and transport
functions.NAT8, which was almost exclu-
sively expressed in renal epithelial cells,
codes for an enzyme that catalyzes trans-
fer of acetyl groups and may participate in
detoxifying xenobiotics. This gene has no
known relationship with CKD. Two solute
and drug transport proteins found in prox-
imal tubule epithelial cells, which mediate
endogenous and xenobiotic transport,
were also highlighted for these properties.
Another gene of interest, UMOD, whose
product is uromodulin, is restricted to
the distal tubule epithelium. Mutations in
this gene are associated with rare causes
of renal disease, and knockout animals
show a reduced GFR. A meta-analysis of
the highlighted UMOD mutant suggests
that the gene has a protective role in CKD.
Several interesting observations can be
drawn from these studies. The genetic452 Cell Metabolism 11, June 9, 2010 ª2010markers were not associated with many
of the more common causes of chronic
renal disease, such as diabetes and
hypertension, nor did they identify associ-
ations with mutants among the genes
in the RAS pathway. The localization of
these genes to the tubule compartment
suggests that the stresses represented
by hypertension, diabetes, and possibly
xenobiotics may impinge on a common
pathway centered in the renal epithelium.
These genes have not been previously
identified as contributing to acute or
chronic renal failure and highlight the
potential of this new technology to identify
novel pathways and targets of treatment
to halt progression to end stage renal
disease.
Some obvious weaknesses in these
studies should be pointed out. Ko¨ttgen
et al. calculate the effect of each locus
on the measured variability of eGFR in
the population. The effect, not unexpect-
edly, is small, accounting for less than
2% of the observed variation in GFR and
suggests that rare variants are yet to be
discovered that will have greater effect
on CKD. The major obstacle to discovery
of such loci is the feasibility of performing
whole-genome sequencing, and newer
technologies are rapidly being developed,
such as by the 1000 Genomes project.
Perhaps the loci may only represent one
gene in a pathway that, when explored,
may have a greater effect in CKD. The
absence of patients of African ancestry
in the study, in which a significant associ-
ation between nondiabetic ESRD with
common variants in the MYH9 gene
coding for nonmuscle myosin heavy-
chain type II has been observed (Kopp
et al., 2008), was not seen in these
studies, raising the question of just how
relevant these studies are to CKD in
humans of non-European ancestry.
Nonetheless, it will be exciting to
witness the exploration of these potentialElsevier Inc.pathways to understand mechanisms of
renal failure, to develop biomarkers of
renal injury, and to exploit these newly
discovered pathways to develop strate-
gies to halt the progression to end stage
renal disease. And it all begins with
humankind.
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